...what you should care about is whether or not this company can make it through the 2nd quarter of 2009...much less the end of 2010 when you'd expect to hear back from the FDA on any kind of application for Genta.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.